相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
Kathryn M. Connor et al.
HEADACHE (2011)
Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)
Simon R. Sinclair et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
Lars Edvinsson et al.
CEPHALALGIA (2010)
Effect of Calcitonin Gene-Related Peptide Receptor Antagonism on the Systemic Blood Pressure Responses to Mechanistically Diverse Vasomodulators in Conscious Rats
Joseph J. Lynch et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Single- and Multiple-Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, in Adults
Tae H. Han et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Triptan Therapy in Migraine
Elizabeth Loder
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Pharmacological characterization of MK-0974 [N-[(3R, 6S)-6(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b] pyridin-1-yl)piperidine-1-carboxamide], a potent and orally Active calcitonin gene-related peptide receptor antagonist for the treatment of migraine
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cardioprotective actions of peptide hormones in myocardial ischemia
Dwaine S. Burley et al.
HEART FAILURE REVIEWS (2007)
Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine:: Discovery of N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide (MK-0974)
Daniel V. Paone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease
D Patterson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Antianginal efficacy of Omapatrilat in patients with chronic angina pectoris
BR Chaitman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris - art. no. e2
SP Glasser et al.
AMERICAN HEART JOURNAL (2005)
Consensus statement:: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine
D Dodick et al.
HEADACHE (2004)
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial
BR Chaitman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Nitric-oxide mediated effects of transdermal capsaicin patches on the ischemic threshold in patients with stable coronary disease
G Fragasso et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina
KM Fox et al.
EUROPEAN HEART JOURNAL (2003)
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease
U Thadani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
The safety of triptans in the treatment of patients with migraine
DG Jamieson
AMERICAN JOURNAL OF MEDICINE (2002)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
分享论文
